In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III global research program — CREDO (Clinical RhEumatoid Arthritis Development...
Haikou city, the administrative center of Hainan, announced the opening of the island's first modern pharmaceutical equipment maintenance facility, TASS reports with a reference...
Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating...
PROMOMED DM LLC publishes financial statements for 9 months of 2021 compiled in accordance with Russian Accounting Standards (RAS).
According to the results of 9...
On September 22-24, the VI All Russia GMP Conference with international participation, organized by the Ministry of Industry and Trade of Russia together with...
The research center of the university will be engaged in the development of new drugs for Russia with improved characteristics of safety and bioavailability profiles, increased stability and ease of use. First of all, they will be innovative pharmaceuticals for women's health, reproductive medicine, neurology and immunology.